Crossmark

Gastric neuroendocrine carcinoma presenting complete durable response by nivolumab treatment for multiple metastases and radiotherapy to oligoprogressive metastasis

Crossref DOI link: https://doi.org/10.1007/s13691-023-00611-z

Published Online: 2023-05-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Seyama, Yusuke

Yamada, Takeshi https://orcid.org/0000-0001-7848-5827
Suzuki, Hirosumi

Fukuda, Satoshi

Tsuji, Miki

Niisato, Yusuke

Hirose, Suguru

Yamamoto, Yoshiyuki

Moriwaki, Toshikazu

Hyodo, Ichinosuke
License Information

Text and Data Mining valid from 2023-05-12

Version of Record valid from 2023-05-12
More Information

Article History

Received: 24 January 2023

Accepted: 24 April 2023

First Online: 12 May 2023

Declarations

:

: I.H. serves as a consultant to Asahi Kasei, Ono, Chugai, Taiho, and Eisai pharmaceutical companies. The other authors declare that they have no conflict of interest.

: The authors declare that this study conformed to the Declaration a Helsinki.

: Informed consent was obtained from the patient for publication of his disease and clinical course.

Document is current

Any future updates will be listed below